BELSOMRA 20 mg/1 (Suvorexant TABLET, FILM COATED) 20 mg/1

Belsomra 20 mg is a prescription medication used to treat insomnia. This film-coated tablet contains suvorexant, a sleep aid designed to help improve sleep patterns. Belsomra is manufactured by Merck Sharp & Dohme LLC in the USA.

Strength

20 mg/1

Pack Size

3 CASE in 1 CARTON (0006-0335-30) / 1 BLISTER PACK in 1 CASE (0006-0335-10) / 10 TABLET, FILM COAT

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Belsomra 20 mg is primarily used for the treatment of insomnia, a sleep disorder characterized by difficulty falling or staying asleep. Suvorexant, the active ingredient, works by targeting specific receptors in the brain to promote sleep. This medication is often prescribed for individuals who struggle with maintaining a regular sleep schedule. People often ask, 'What is Belsomra used for?' and the answer is that it is designed to help those who have trouble sleeping through the night.

Side Effects

Common effects of Belsomra 20 mg may include drowsiness, headache, and dizziness. Some users might experience unusual dreams or a metallic taste in the mouth. These effects can vary from person to person and are generally mild. It's important to note that individual responses to the medication can differ.

Precautions & Warnings

Belsomra 20 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be taken with alcohol or other sedatives unless directed by a doctor. Always store Belsomra in a cool, dry place away from direct sunlight.

Avoid Interactions

Belsomra 20 mg may interact with certain medications, including other sedatives, antidepressants, and medications that affect the central nervous system. It is crucial to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions. Alcohol should be avoided while taking Belsomra, as it can enhance the sedative effects.

Frequently Asked Questions

Belsomra 20 mg is used to treat insomnia, helping individuals fall asleep and stay asleep throughout the night.

Belsomra should be taken orally, typically before bedtime, as directed by your healthcare provider.

Common side effects may include drowsiness, headache, dizziness, unusual dreams, and a metallic taste in the mouth.

It is important to consult your healthcare provider before taking Belsomra with other medications, especially sedatives or antidepressants.

No, alcohol should be avoided while taking Belsomra, as it can enhance the sedative effects.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.